Cabot (NYSE:CBT) Upgraded by Zacks Research to Hold Rating

Cabot (NYSE:CBTGet Free Report) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Tuesday,Zacks.com reports.

A number of other analysts also recently commented on CBT. Mizuho boosted their target price on Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a research report on Thursday, December 18th. Jefferies Financial Group reissued a “buy” rating and issued a $81.00 price objective on shares of Cabot in a research note on Thursday, January 8th. JPMorgan Chase & Co. cut their target price on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research report on Friday, November 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cabot in a research report on Monday, December 29th. Finally, UBS Group lifted their price objective on Cabot from $65.00 to $74.00 and gave the stock a “neutral” rating in a research report on Monday, January 12th. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $72.25.

Check Out Our Latest Analysis on Cabot

Cabot Trading Down 0.1%

NYSE CBT opened at $71.52 on Tuesday. The company has a quick ratio of 1.08, a current ratio of 1.61 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $3.78 billion, a P/E ratio of 11.90, a P/E/G ratio of 3.75 and a beta of 0.89. Cabot has a 52-week low of $58.33 and a 52-week high of $89.16. The firm has a 50-day moving average price of $67.66 and a 200 day moving average price of $71.76.

Cabot (NYSE:CBTGet Free Report) last released its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.72 by ($0.02). Cabot had a return on equity of 24.55% and a net margin of 8.91%.The business had revenue of $899.00 million for the quarter, compared to analyst estimates of $967.02 million. During the same quarter in the previous year, the firm posted $1.80 EPS. The business’s revenue for the quarter was down 10.2% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Equities research analysts expect that Cabot will post 7.57 EPS for the current year.

Institutional Investors Weigh In On Cabot

Several hedge funds have recently modified their holdings of the stock. Penserra Capital Management LLC grew its holdings in Cabot by 65.7% during the 2nd quarter. Penserra Capital Management LLC now owns 6,609 shares of the specialty chemicals company’s stock worth $495,000 after acquiring an additional 2,620 shares in the last quarter. First Citizens Bank & Trust Co. grew its stake in Cabot by 144.4% in the second quarter. First Citizens Bank & Trust Co. now owns 14,352 shares of the specialty chemicals company’s stock worth $1,076,000 after purchasing an additional 8,479 shares in the last quarter. American Century Companies Inc. increased its holdings in Cabot by 11.1% in the second quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock valued at $124,855,000 after buying an additional 166,460 shares during the last quarter. Sequoia Financial Advisors LLC acquired a new stake in Cabot during the second quarter valued at approximately $436,000. Finally, Paradiem LLC grew its position in shares of Cabot by 65.5% in the 3rd quarter. Paradiem LLC now owns 149,097 shares of the specialty chemicals company’s stock worth $11,339,000 after acquiring an additional 59,030 shares in the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Company Profile

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Read More

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.